<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="b2d6e17b-f14a-463b-a662-03c9387c63dd"><labelDrug name="Edarbyclor"><Normalization><mmtx cui="C3264880" preferredWord="Edarbyclor" semType="phsu"/></Normalization></labelDrug><generic name="azilsartan medoxomil and chlorthalidone"/><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1" text="Drug Label for drug brand Edarbyclor, containing azilsartan medoxomil and chlorthalidone." type="negative"><entity charOffset="49:69" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.0" text="azilsartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C2698291" phraseText="azilsartan medoxomil" preferredWord="azilsartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="26:36" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.1" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="Drug Label for drug brand Edarbyclor," preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="74:88" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.2" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone." preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.3" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Edarbyclor," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.1.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11" lineNumber="33" text="&lt;item&gt;Do not coadminister aliskiren with Edarbyclor in patients with diabetes see Drug Interactions (7)." type="regular"><entity charOffset="6:25" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="26:35" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Edarbyclor" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.3" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="aliskiren with Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.0"><relations><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.4" ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.11.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13" lineNumber="41" text="&lt;item&gt;Do not coadminister aliskiren with Edarbyclor in patients with diabetes (4)" type="regular"><entity charOffset="6:25" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="26:35" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Edarbyclor" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="41:51" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.3" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="aliskiren with Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.4" ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.13.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15" text="&lt;item&gt;In patients with an activated renin-angiotensin-aldosterone system (RAAS), such as volume- and/or salt-depleted patients, Edarbyclor can cause excessive hypotension. " type="negative"><entity charOffset="42:53" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin-aldosterone system (RAAS)," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="128:138" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.1" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="54:65" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.2" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="with an activated renin-angiotensin-aldosterone system (RAAS)," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.15.e.1"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30" text="In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with Edarbyclor. " type="negative"><entity charOffset="225:235" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.0" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="with Edarbyclor." preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="144:153" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="treated with high doses of diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.30.e.2"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.38" text="As a consequence of inhibiting the renin-angiotensin system, changes in renal function may be anticipated in susceptible individuals treated with Edarbyclor. " type="negative"><entity charOffset="146:156" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.38.e.0" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="treated with Edarbyclor." preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.38.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.38.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.38.e.0"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39" text="In patients whose renal function may depend on the activity of the renin-angiotensin system (e.g., patients with severe congestive heart failure, renal artery stenosis, or volume depletion), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers has been associated with oliguria or progressive azotemia and rarely with acute renal failure and death. " type="negative"><entity charOffset="251:280" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.0" text="angiotensin receptor blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor blockers" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="206:246" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.1" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.39.e.1"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.41" text="In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen have been reported. " type="negative"><entity charOffset="132:136" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.41.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="blood urea nitrogen" preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="14:28" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.41.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.41.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.41.e.0"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.44" text="If progressive renal impairment becomes evident, as indicated by increased blood urea nitrogen, consider withholding or discontinuing diuretic therapy." type="negative"><entity charOffset="81:85" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.44.e.0" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="indicated by increased blood urea nitrogen," preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><entity charOffset="134:142" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.44.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="discontinuing diuretic therapy." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.44.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.44.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47" lineNumber="81" text="Co-administration of digitalis may exacerbate the adverse effects of hypokalemia." type="irregular"><entity charOffset="21:30" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47.e.0" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="Co-administration of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="35:80" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47.e.1" text="exacerbate the adverse effects of hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47.e.1"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.47.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.46" text="Hypokalemia is a dose-dependent adverse reaction that may develop with chlorthalidone. "><entity charOffset="71:85" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.46.e.0" text="chlorthalidone" type="Drug"><Normalization><mmtx cui="C0008294" phraseText="develop with chlorthalidone." preferredWord="Chlorthalidone" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48" lineNumber="82" text="Edarbyclor attenuates chlorthalidone-associated hypokalemia. " type="regular"><entity charOffset="0:10" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.0" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="22:36" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.1" text="chlorthalidone" type="Drug"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone-associated hypokalemia." preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="11:21|48:59" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.2" text="attenuates hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.1" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.48.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49" text="In patients with normal potassium levels at baseline, 1.7% of Edarbyclor-treated patients, 0.9% of azilsartan medoxomil-treated patients, and 13.4% of chlorthalidone-treated patients shifted to low potassium values (less than 3.4 mmol/L)." type="negative"><entity charOffset="24:33" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="with normal potassium levels" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="99:119" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.1" text="azilsartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C2698291" phraseText="0.9% of azilsartan medoxomil-treated patients," preferredWord="azilsartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="62:72" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.2" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="1.7% of Edarbyclor-treated patients," preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="198:207" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.3" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="shifted to low potassium values" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="151:165" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.4" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="13.4% of chlorthalidone-treated patients" preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.49.e.3"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.51" text="Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving chlorthalidone or other thiazide diuretics." type="negative"><entity charOffset="88:102" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.51.e.0" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone" preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="112:130" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.51.e.1" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="other thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.51.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.51.e.1"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.53" text="The pharmacokinetics of azilsartan medoxomil and chlorthalidone are not altered when the drugs are co-administered." type="negative"><entity charOffset="24:44" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.53.e.0" text="azilsartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C2698291" phraseText="The pharmacokinetics of azilsartan medoxomil" preferredWord="azilsartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="49:63" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.53.e.1" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone" preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.53.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.53.e.1"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54" text="No drug interaction studies have been conducted with other drugs and Edarbyclor, although studies have been conducted with azilsartan medoxomil and chlorthalidone." type="negative"><entity charOffset="69:79" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.0" text="edarbyclor" type="Biomedical_Entity"><Normalization><mmtx cui="C3264880" phraseText="Edarbyclor," preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="123:143" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.1" text="azilsartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C2698291" phraseText="conducted with azilsartan medoxomil" preferredWord="azilsartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="148:162" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.2" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone." preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.54.e.2"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55" text="No clinically significant drug interactions have been observed in studies of azilsartan medoxomil or azilsartan given with amlodipine, antacids, chlorthalidone, digoxin, fluconazole, glyburide, ketoconazole, metformin, pioglitazone, and warfarin. " type="negative"><entity charOffset="101:111" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" text="azilsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1958569" phraseText="azilsartan" preferredWord="azilsartan" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="135:143" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" text="antacids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003138" phraseText="antacids," preferredWord="Antacids" semType="phsu"/><RxNorm RxCui="863"/></Normalization></entity><entity charOffset="194:206" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="237:245" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="145:159" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" text="chlorthalidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0008294" phraseText="chlorthalidone," preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="170:181" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" text="fluconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0016277" phraseText="fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="219:231" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6" text="pioglitazone" type="Biomedical_Entity"><Normalization><mmtx cui="C0071097" phraseText="pioglitazone," preferredWord="pioglitazone" semType="phsu, orch"/><RxNorm RxCui="33738"/></Normalization></entity><entity charOffset="123:133" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="given with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="161:168" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="77:97" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" text="azilsartan medoxomil" type="Biomedical_Entity"><Normalization><mmtx cui="C2698291" phraseText="observed in studies of azilsartan medoxomil" preferredWord="azilsartan medoxomil" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="183:192" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glyburide," preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="208:217" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11" text="metformin" type="Biomedical_Entity"><Normalization><mmtx cui="C0025598" phraseText="metformin," preferredWord="Metformin" semType="phsu, orch"/><RxNorm RxCui="235743"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.3"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.4" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.5" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.6"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.7" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.8" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.9" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.10" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.55.e.11"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="0:38" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.0" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.1" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><entity charOffset="88:104" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.2" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.1"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.57.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58" lineNumber="95" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or who have compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including azilsartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="20:27" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.0" text="elderly" type="SPAN"/><entity charOffset="29:44" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="96:122" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="145:151" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="163:189" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="196:231" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.5" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="243:253" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.6" text="azilsartan" type="Drug"><Normalization><mmtx cui="C1958569" phraseText="azilsartan," preferredWord="azilsartan" semType="phsu, orch"/><RxNorm RxCui="1091643"/></Normalization></entity><entity charOffset="269:300" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="321:340" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.4"/><drugClassMembership drug="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.6" drugClass="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.5"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.7"><relations><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.9"><relations><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.2, Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.0, Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.1" ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.5" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.58.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60" lineNumber="95" text="Monitor renal function periodically in patients receiving Edarbyclor and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:68" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.2" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.60.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61" lineNumber="96" text="The antihypertensive effect of Edarbyclor may be attenuated by NSAIDs, including selective COX-2 inhibitors." type="regular"><entity charOffset="63:69" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="81:107" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.1" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="31:41" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="The antihypertensive effect of Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="4:27|49:59" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.4" text="antihypertensive effect attenuated" type="Specific_Interaction"/><classClassMembership drugClass="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.1"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.4"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.0" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.4" type="Specific_Interaction"/></sentence><sentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="5:13" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62.e.0" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63" lineNumber="98" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="30:59" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="128:139" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.3" text="hypotension" type="Specific_Interaction"/><entity charOffset="141:153" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.5" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.7" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61" text="The antihypertensive effect of Edarbyclor may be attenuated by NSAIDs, including selective COX-2 inhibitors."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61" text="The antihypertensive effect of Edarbyclor may be attenuated by NSAIDs, including selective COX-2 inhibitors."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.ddi.3"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61" text="The antihypertensive effect of Edarbyclor may be attenuated by NSAIDs, including selective COX-2 inhibitors."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.ddi.4"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.9"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61" text="The antihypertensive effect of Edarbyclor may be attenuated by NSAIDs, including selective COX-2 inhibitors."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.61.e.3"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.62" text="Dual Blockade of the Renin-Angiotensin System (RAS)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/><pair ddi="false" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.63.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64" lineNumber="98" text="Closely monitor blood pressure, renal function and electrolytes in patients on Edarbyclor and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.0" text="monitor" type="Caution_Interaction"/><entity charOffset="79:89" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.2" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="on Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="100:126" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.0"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.64.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65" lineNumber="99" text="Do not coadminister aliskiren with Edarbyclor in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.0" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Edarbyclor" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:45" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.3" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="aliskiren with Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="63:71" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.0"><relations><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.4" ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.65.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66" lineNumber="99" text="Avoid use of aliskiren with Edarbyclor in patients with renal impairment (GFR 60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:38" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.3" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="with Edarbyclor" preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="56:72" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.0"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.4" ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.66.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67" lineNumber="100" text="Lithium renal clearance is reduced by diuretics, such as chlorthalidone, increasing the risk of lithium toxicity. " type="regular"><entity charOffset="8:34" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.0" text="renal clearance is reduced" type="Increase_Interaction"/><entity charOffset="0:7" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium renal clearance" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="38:47" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="reduced by diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="57:71" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.4" text="chlorthalidone" type="Drug"><Normalization><mmtx cui="C0008294" phraseText="such as chlorthalidone," preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="104:112" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.6" text="toxicity" type="Increase_Interaction"/><entity charOffset="96:103" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.8" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugClassMembership drug="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.4" drugClass="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.0"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.8" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.67.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" lineNumber="100" text="Consider monitoring lithium levels when using Edarbyclor." type="regular"><entity charOffset="20:27" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.0" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="monitoring lithium levels" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="46:56" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1" text="Edarbyclor" type="Drug"><Normalization><mmtx cui="C3264880" phraseText="Edarbyclor." preferredWord="Edarbyclor" semType="phsu"/><RxNorm RxCui="1372759"/></Normalization></entity><entity charOffset="9:19" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.2"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.0" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" lineNumber="103" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)" type="regular"><entity charOffset="6:21|33:43" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.0" text="Renal clearance is reduced" type="Increase_Interaction"/><entity charOffset="25:32" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="&gt;Renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="47:56" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="reduced by diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="66:80" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.4" text="chlorthalidone" type="Drug"><Normalization><mmtx cui="C0008294" phraseText="such as chlorthalidone" preferredWord="Chlorthalidone" semType="phsu, orch"/><RxNorm RxCui="2409"/></Normalization></entity><entity charOffset="104:111" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="112:120" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.7" text="toxicity" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.4" drugClass="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.0"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.7"><relations><relation type="hasObject"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.2" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.3" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.6" trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69.e.7" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70" lineNumber="105" text="&lt;item&gt;NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect (7)" type="irregular"><entity charOffset="6:12" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.0" text="NSAIDS" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDS" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="30:47" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.1" text="renal dysfunction" type="Specific_Interaction"/><entity charOffset="52:90" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.3" text="interfere with antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" text="Consider monitoring lithium levels when using Edarbyclor."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" text="Consider monitoring lithium levels when using Edarbyclor."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71" lineNumber="107" text="&lt;item&gt;Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7)" type="irregular"><entity charOffset="73:89" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.0" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="Increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="Increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="91:102" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="108:120" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.4" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="11:53" id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.6" text="inhibition of the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C0035100" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="986536"/></Normalization></entity><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.ddi.1"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" text="Consider monitoring lithium levels when using Edarbyclor."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)"/><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70" text="&lt;item&gt;NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect (7)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.ddi.2"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.2"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" text="Consider monitoring lithium levels when using Edarbyclor."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)"/><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70" text="&lt;item&gt;NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect (7)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.ddi.3"><interaction trigger="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68" text="Consider monitoring lithium levels when using Edarbyclor."><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.68.e.1"/></ellipsisSentence><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.69" text="&lt;item&gt;Renal clearance of lithium is reduced by diuretics, such as chlorthalidone increasing the risk of lithium toxicity (7)"/><middleSentence id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.70" text="&lt;item&gt;NSAIDS increase risk of renal dysfunction and interfere with antihypertensive effect (7)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.b2d6e17b-f14a-463b-a662-03c9387c63dd.s.71.e.6"/></sentence><positiveExamples number="19"/><negativeExamples number="104"/></document>